Dynamic Technology Lab Private LTD Replimune Group, Inc. Transaction History

Dynamic Technology Lab Private LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $555,864 - $925,062	31,800 New	31,800 $561,000
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $186,376 - $251,018	-7,329 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.98 - $39.54 $212,394 - $289,788	7,329 New	7,329 $217,000
Q2 2021 Aug 13, 2021	SELL	$28.5 - $39.37 $223,440 - $308,660	-7,840 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$30.22 - $45.57 $236,924 - $357,268	7,840 New	7,840 $239,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.